CHMP approves 13 new drugs
During its monthly December meeting, the European Medicines Agency's (EMA) special committee, the CHMP, has recommended 13 drugs for approval and rejected one – an additional six drugs have received the green light to expand indications.
by MIKKEL AABENHUS HEMMINGSEN, translated by daniel pedersen
A string of new treatments has received the go-ahead from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP).
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Biogen's Aduhelm rejected by EMA committee
For subscribers
.jpg&w=384&q=75)
